--2024/Q4-- / 3.798B--
Oct 31, 20242024/Q3-- / 3.665B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 1000.090
- +1.860+0.19%
Trading Oct 18 13:30 ET
110.24BMarket Cap26.48P/E (TTM)
1001.920High991.620Low293.84KVolume998.000Open998.230Pre Close293.39MTurnover0.28%Turnover Ratio28.76P/E (Static)110.23MShares1211.20052wk High3.91P/B105.76BFloat Cap769.19052wk Low--Dividend TTM105.75MShs Float1211.200Historical High--Div YieldTTM1.03%Amplitude4.610Historical Low998.440Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Regeneron Pharmaceuticals Q3 2024 Estimates Date
Currency：USDOct 31, 2024
| Estimate | YoY | |
| Revenue | 3.66B | +8.90% |
| EPS | 9.60 | +7.97% |
Analyst Rating
Oct 18, 2024
Regeneron Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Regeneron Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
